Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Anupam Rama is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | ZLAB | Buy Now | Zai Lab | $37.92 | 34.49% | Anupam Rama61% | $44 → $51 | Maintains | Overweight | Get Alert |
| 03/13/2025 | SLDB | Buy Now | Solid Biosciences | $5.01 | 119.56% | Anupam Rama61% | $12 → $11 | Maintains | Overweight | Get Alert |
| 03/05/2025 | DAWN | Buy Now | Day One Biopharmaceutical | $8.16 | 316.67% | Anupam Rama61% | $39 → $34 | Maintains | Overweight | Get Alert |
| 03/05/2025 | ANAB | Buy Now | AnaptysBio | $16.14 | 160.22% | Anupam Rama61% | $36 → $42 | Maintains | Overweight | Get Alert |
| 03/04/2025 | VERA | Buy Now | Vera Therapeutics | $27.41 | 159.03% | Anupam Rama61% | $77 → $71 | Maintains | Overweight | Get Alert |
| 03/04/2025 | SNDX | Buy Now | Syndax Pharmaceuticals | $12.62 | 209.03% | Anupam Rama61% | $35 → $39 | Maintains | Overweight | Get Alert |
| 03/04/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 121.22% | Anupam Rama61% | $50 → $54 | Maintains | Overweight | Get Alert |
| 02/26/2025 | TVTX | Buy Now | Travere Therapeutics | $19.84 | 121.77% | Anupam Rama61% | $42 → $44 | Maintains | Overweight | Get Alert |
| 02/26/2025 | REPL | Buy Now | Replimune Group | $11.43 | 57.48% | Anupam Rama61% | $16 → $18 | Maintains | Overweight | Get Alert |
| 02/26/2025 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.63 | 188.34% | Anupam Rama61% | $21 → $22 | Maintains | Overweight | Get Alert |
| 02/25/2025 | MAZE | Buy Now | Maze Therapeutics | $11.49 | 161.1% | Anupam Rama61% | → $30 | Initiates | → Overweight | Get Alert |
| 02/06/2025 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.63 | 175.23% | Anupam Rama61% | $19 → $21 | Maintains | Overweight | Get Alert |
| 12/19/2024 | ANAB | Buy Now | AnaptysBio | $16.14 | 123.05% | Anupam Rama61% | $66 → $36 | Maintains | Overweight | Get Alert |
| 11/21/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 162.48% | Anupam Rama61% | $105 → $102 | Maintains | Overweight | Get Alert |
| 11/21/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $12.62 | 201.11% | Anupam Rama61% | $33 → $38 | Maintains | Overweight | Get Alert |
| 11/14/2024 | COGT | Buy Now | Cogent Biosciences | $7.25 | 189.66% | Anupam Rama61% | $19 → $21 | Maintains | Overweight | Get Alert |
| 11/12/2024 | SLDB | Buy Now | Solid Biosciences | $5.01 | 139.52% | Anupam Rama61% | $15 → $12 | Maintains | Overweight | Get Alert |
| 11/12/2024 | ANAB | Buy Now | AnaptysBio | $16.14 | 308.92% | Anupam Rama61% | $75 → $66 | Maintains | Overweight | Get Alert |
| 11/12/2024 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 89.11% | Anupam Rama61% | $16 → $17 | Maintains | Overweight | Get Alert |
| 11/11/2024 | RAPT | Buy Now | RAPT Therapeutics | $1.10 | — | Anupam Rama61% | — | Downgrade | Neutral → Underweight | Get Alert |
| 11/05/2024 | VERA | Buy Now | Vera Therapeutics | $27.41 | 173.62% | Anupam Rama61% | $72 → $75 | Maintains | Overweight | Get Alert |
| 11/05/2024 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $22.61 | 76.91% | Anupam Rama61% | $39 → $40 | Maintains | Overweight | Get Alert |
| 10/21/2024 | ZLAB | Buy Now | Zai Lab | $37.92 | 16.03% | Anupam Rama61% | $38 → $44 | Maintains | Overweight | Get Alert |
| 10/04/2024 | NUVL | Buy Now | Nuvalent | $76.66 | 63.06% | Anupam Rama61% | $100 → $125 | Maintains | Overweight | Get Alert |
| 09/30/2024 | PROK | Buy Now | ProKidney | $1.00 | — | Anupam Rama61% | — | Initiates | → Neutral | Get Alert |
| 09/24/2024 | REPL | Buy Now | Replimune Group | $11.43 | 48.73% | Anupam Rama61% | $14 → $17 | Maintains | Overweight | Get Alert |
| 09/13/2024 | TVTX | Buy Now | Travere Therapeutics | $19.84 | 15.93% | Anupam Rama61% | $20 → $23 | Maintains | Overweight | Get Alert |
| 09/13/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 133.51% | Anupam Rama61% | $64 → $57 | Maintains | Overweight | Get Alert |
| 09/04/2024 | NUVL | Buy Now | Nuvalent | $76.66 | 30.45% | Anupam Rama61% | $90 → $100 | Maintains | Overweight | Get Alert |
| 09/04/2024 | SWTX | Buy Now | SpringWorks Therapeutics | $49.65 | 36.96% | Anupam Rama61% | $64 → $68 | Maintains | Overweight | Get Alert |
| 09/03/2024 | VERA | Buy Now | Vera Therapeutics | $27.41 | 162.68% | Anupam Rama61% | $62 → $72 | Maintains | Overweight | Get Alert |
| 08/16/2024 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 77.99% | Anupam Rama61% | $17 → $16 | Maintains | Overweight | Get Alert |
| 08/13/2024 | VERA | Buy Now | Vera Therapeutics | $27.41 | 126.19% | Anupam Rama61% | $65 → $62 | Maintains | Overweight | Get Alert |
| 08/13/2024 | REPL | Buy Now | Replimune Group | $11.43 | 22.48% | Anupam Rama61% | $17 → $14 | Maintains | Overweight | Get Alert |
| 08/13/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 162.19% | Anupam Rama61% | $72 → $64 | Maintains | Overweight | Get Alert |
| 08/13/2024 | TVTX | Buy Now | Travere Therapeutics | $19.84 | 0.81% | Anupam Rama61% | $19 → $20 | Maintains | Overweight | Get Alert |
| 08/08/2024 | OLMA | Buy Now | Olema Pharmaceuticals | $4.00 | 674.94% | Anupam Rama61% | $33 → $31 | Maintains | Overweight | Get Alert |
| 08/08/2024 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 257.34% | Anupam Rama61% | $69 → $66 | Maintains | Overweight | Get Alert |
| 08/07/2024 | COGT | Buy Now | Cogent Biosciences | $7.25 | 162.07% | Anupam Rama61% | $22 → $19 | Maintains | Overweight | Get Alert |
| 08/07/2024 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 36.51% | Anupam Rama61% | $46 → $43 | Maintains | Overweight | Get Alert |
| 08/07/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | 65% | Anupam Rama61% | $173 → $181 | Maintains | Overweight | Get Alert |
| 08/07/2024 | ANAB | Buy Now | AnaptysBio | $16.14 | 364.68% | Anupam Rama61% | $69 → $75 | Maintains | Overweight | Get Alert |
| 08/06/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $12.62 | 161.49% | Anupam Rama61% | $34 → $33 | Maintains | Overweight | Get Alert |
| 08/06/2024 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 27.55% | Anupam Rama61% | $12 → $10 | Maintains | Neutral | Get Alert |
| 08/06/2024 | DAWN | Buy Now | Day One Biopharmaceutical | $8.16 | 341.18% | Anupam Rama61% | $38 → $36 | Maintains | Overweight | Get Alert |
| 07/25/2024 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 53.06% | Anupam Rama61% | $18 → $12 | Downgrade | Overweight → Neutral | Get Alert |
| 07/19/2024 | ANAB | Buy Now | AnaptysBio | $16.14 | 327.51% | Anupam Rama61% | $29 → $69 | Upgrade | Neutral → Overweight | Get Alert |
| 07/15/2024 | SLDB | Buy Now | Solid Biosciences | $5.01 | 199.4% | Anupam Rama61% | $10 → $15 | Upgrade | Neutral → Overweight | Get Alert |
| 07/12/2024 | ZLAB | Buy Now | Zai Lab | $37.92 | 0.21% | Anupam Rama61% | $43 → $38 | Maintains | Overweight | Get Alert |
| 07/12/2024 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 129.59% | Anupam Rama61% | $23 → $18 | Maintains | Overweight | Get Alert |
| 07/12/2024 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 273.58% | Anupam Rama61% | $65 → $69 | Maintains | Overweight | Get Alert |
| 07/10/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | 57.7% | Anupam Rama61% | $169 → $173 | Maintains | Overweight | Get Alert |
| 06/20/2024 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 193.37% | Anupam Rama61% | $28 → $23 | Maintains | Overweight | Get Alert |
| 05/31/2024 | VERA | Buy Now | Vera Therapeutics | $27.41 | 137.14% | Anupam Rama61% | $60 → $65 | Maintains | Overweight | Get Alert |
| 05/31/2024 | SLDB | Buy Now | Solid Biosciences | $5.01 | 99.6% | Anupam Rama61% | $12 → $10 | Maintains | Neutral | Get Alert |
| 05/21/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $12.62 | 169.41% | Anupam Rama61% | $34 → $34 | Maintains | Overweight | Get Alert |
| 05/15/2024 | RLYB | Buy Now | Rallybio | $0.74 | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 05/03/2024 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 139.33% | Anupam Rama61% | $177 → $175 | Maintains | Overweight | Get Alert |
| 05/01/2024 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 257.14% | Anupam Rama61% | $29 → $28 | Maintains | Overweight | Get Alert |
| 05/01/2024 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $22.61 | 32.68% | Anupam Rama61% | $26 → $30 | Maintains | Overweight | Get Alert |
| 04/22/2024 | DAWN | Buy Now | Day One Biopharmaceutical | $8.16 | 341.18% | Anupam Rama61% | $32 → $36 | Maintains | Overweight | Get Alert |
| 04/22/2024 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | — | Anupam Rama61% | — | Upgrade | Underweight → Neutral | Get Alert |
| 04/01/2024 | ANAB | Buy Now | AnaptysBio | $16.14 | 73.48% | Anupam Rama61% | $30 → $28 | Maintains | Neutral | Get Alert |
| 04/01/2024 | ANNX | Buy Now | Annexon | $2.62 | 396.18% | Anupam Rama61% | $11 → $13 | Maintains | Overweight | Get Alert |
| 03/27/2024 | RAPT | Buy Now | RAPT Therapeutics | $1.10 | 1081.82% | Anupam Rama61% | $15 → $13 | Maintains | Neutral | Get Alert |
| 03/27/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.63 | 135.91% | Anupam Rama61% | $19 → $18 | Maintains | Overweight | Get Alert |
| 03/26/2024 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 269.9% | Anupam Rama61% | $24 → $29 | Maintains | Overweight | Get Alert |
| 03/20/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $12.62 | 169.41% | Anupam Rama61% | $31 → $34 | Maintains | Overweight | Get Alert |
| 03/20/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | 44.03% | Anupam Rama61% | $148 → $158 | Maintains | Overweight | Get Alert |
| 03/20/2024 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 42.86% | Anupam Rama61% | $35 → $45 | Maintains | Overweight | Get Alert |
| 03/18/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $38.86 | 136.75% | Anupam Rama61% | $88 → $92 | Maintains | Overweight | Get Alert |
| 03/18/2024 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 111.36% | Anupam Rama61% | $21 → $19 | Maintains | Overweight | Get Alert |
| 03/06/2024 | SWTX | Buy Now | SpringWorks Therapeutics | $49.65 | 51.06% | Anupam Rama61% | $73 → $74 | Maintains | Overweight | Get Alert |
| 03/06/2024 | NUVL | Buy Now | Nuvalent | $76.66 | 27.84% | Anupam Rama61% | $68 → $98 | Maintains | Overweight | Get Alert |
| 03/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 223.64% | Anupam Rama61% | $78 → $79 | Maintains | Overweight | Get Alert |
| 03/01/2024 | ANNX | Buy Now | Annexon | $2.62 | 319.85% | Anupam Rama61% | $11 → $11 | Upgrade | Neutral → Overweight | Get Alert |
| 02/27/2024 | COGT | Buy Now | Cogent Biosciences | $7.25 | 175.86% | Anupam Rama61% | $18 → $20 | Maintains | Overweight | Get Alert |
| 02/23/2024 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | 34.91% | Anupam Rama61% | $154 → $148 | Maintains | Overweight | Get Alert |
| 02/23/2024 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 208.61% | Anupam Rama61% | $51 → $57 | Maintains | Overweight | Get Alert |
| 02/21/2024 | RAPT | Buy Now | RAPT Therapeutics | $1.10 | 1263.64% | Anupam Rama61% | $35 → $15 | Downgrade | Overweight → Neutral | Get Alert |
| 12/22/2023 | ALVR | Buy Now | AlloVir | $9.67 | — | Anupam Rama61% | — | Downgrade | Overweight → Underweight | Get Alert |
| 12/08/2023 | COGT | Buy Now | Cogent Biosciences | $7.25 | 148.28% | Anupam Rama61% | → $18 | Initiates | → Overweight | Get Alert |
| 11/30/2023 | VERA | Buy Now | Vera Therapeutics | $27.41 | -19.74% | Anupam Rama61% | $25 → $22 | Maintains | Overweight | Get Alert |
| 11/30/2023 | ZLAB | Buy Now | Zai Lab | $37.92 | 74.05% | Anupam Rama61% | $64 → $66 | Maintains | Overweight | Get Alert |
| 11/30/2023 | RAPT | Buy Now | RAPT Therapeutics | $1.10 | 3081.82% | Anupam Rama61% | $32 → $35 | Maintains | Overweight | Get Alert |
| 11/30/2023 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 121.98% | Anupam Rama61% | $35 → $41 | Maintains | Overweight | Get Alert |
| 10/31/2023 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 57.28% | Anupam Rama61% | $211 → $115 | Maintains | Overweight | Get Alert |
| 10/17/2023 | ZLAB | Buy Now | Zai Lab | $37.92 | 68.78% | Anupam Rama61% | $67 → $64 | Maintains | Overweight | Get Alert |
| 10/17/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $12.62 | 201.11% | Anupam Rama61% | $36 → $38 | Maintains | Overweight | Get Alert |
| 10/06/2023 | GTHX | Buy Now | G1 Therapeutics | — | — | Anupam Rama61% | — | Downgrade | Neutral → Underweight | Get Alert |
| 10/06/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 231.83% | Anupam Rama61% | $60 → $81 | Upgrade | Neutral → Overweight | Get Alert |
| 10/05/2023 | NUVL | Buy Now | Nuvalent | $76.66 | -11.3% | Anupam Rama61% | $51 → $68 | Maintains | Overweight | Get Alert |
| 09/29/2023 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 111.36% | Anupam Rama61% | $17 → $19 | Maintains | Overweight | Get Alert |
| 09/15/2023 | OLMA | Buy Now | Olema Pharmaceuticals | $4.00 | 374.96% | Anupam Rama61% | $16 → $19 | Maintains | Overweight | Get Alert |
| 09/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | 22.15% | Anupam Rama61% | $133 → $134 | Maintains | Overweight | Get Alert |
| 08/17/2023 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 20.63% | Anupam Rama61% | $42 → $38 | Maintains | Overweight | Get Alert |
| 08/17/2023 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 73.25% | Anupam Rama61% | $28 → $32 | Maintains | Overweight | Get Alert |
| 08/16/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $12.62 | 161.49% | Anupam Rama61% | $36 → $33 | Maintains | Overweight | Get Alert |
| 08/16/2023 | RAPT | Buy Now | RAPT Therapeutics | $1.10 | 2809.09% | Anupam Rama61% | $39 → $32 | Maintains | Overweight | Get Alert |
| 08/16/2023 | GBIO | Buy Now | Generation Bio | $0.57 | 1478.95% | Anupam Rama61% | $8 → $9 | Maintains | Neutral | Get Alert |
| 08/10/2023 | RLYB | Buy Now | Rallybio | $0.74 | 2331.45% | Anupam Rama61% | $17 → $18 | Maintains | Overweight | Get Alert |
| 08/10/2023 | OLMA | Buy Now | Olema Pharmaceuticals | $4.00 | 299.97% | Anupam Rama61% | $14 → $16 | Maintains | Overweight | Get Alert |
| 08/03/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 145.8% | Anupam Rama61% | $72 → $60 | Downgrade | Overweight → Neutral | Get Alert |
| 07/25/2023 | KOD | Buy Now | Kodiak Sciences | $3.24 | — | Anupam Rama61% | — | Downgrade | Neutral → Underweight | Get Alert |
| 07/21/2023 | TVTX | Buy Now | Travere Therapeutics | $19.84 | 31.05% | Anupam Rama61% | → $26 | Initiates | → Overweight | Get Alert |
| 07/20/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 194.96% | Anupam Rama61% | $100 → $72 | Maintains | Overweight | Get Alert |
| 06/23/2023 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 191.3% | Anupam Rama61% | $217 → $213 | Maintains | Overweight | Get Alert |
| 06/23/2023 | NUVL | Buy Now | Nuvalent | $76.66 | -37.39% | Anupam Rama61% | $37 → $48 | Maintains | Overweight | Get Alert |
| 06/15/2023 | REPL | Buy Now | Replimune Group | $11.43 | 337.45% | Anupam Rama61% | $38 → $50 | Maintains | Overweight | Get Alert |
| 05/25/2023 | ANNX | Buy Now | Annexon | $2.62 | 243.51% | Anupam Rama61% | $19 → $9 | Downgrade | Overweight → Neutral | Get Alert |
| 05/22/2023 | ANAB | Buy Now | AnaptysBio | $16.14 | 85.87% | Anupam Rama61% | $31 → $30 | Upgrade | Underweight → Neutral | Get Alert |
| 04/12/2023 | VERA | Buy Now | Vera Therapeutics | $27.41 | -19.74% | Anupam Rama61% | $38 → $22 | Maintains | Overweight | Get Alert |
| 04/12/2023 | ANAB | Buy Now | AnaptysBio | $16.14 | 92.07% | Anupam Rama61% | $32 → $31 | Maintains | Underweight | Get Alert |
| 04/04/2023 | KOD | Buy Now | Kodiak Sciences | $3.24 | 208.64% | Anupam Rama61% | $12 → $10 | Maintains | Neutral | Get Alert |
| 03/21/2023 | RAPT | Buy Now | RAPT Therapeutics | $1.10 | 3718.18% | Anupam Rama61% | $48 → $42 | Maintains | Overweight | Get Alert |
| 03/21/2023 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.63 | 96.59% | Anupam Rama61% | $16 → $15 | Maintains | Overweight | Get Alert |
| 03/16/2023 | ZLAB | Buy Now | Zai Lab | $37.92 | 84.6% | Anupam Rama61% | $79 → $70 | Maintains | Overweight | Get Alert |
| 03/09/2023 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $22.61 | -11.54% | Anupam Rama61% | $19 → $20 | Maintains | Overweight | Get Alert |
| 03/07/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $12.62 | 185.26% | Anupam Rama61% | $41 → $36 | Maintains | Overweight | Get Alert |
| 03/07/2023 | SWTX | Buy Now | SpringWorks Therapeutics | $49.65 | 14.8% | Anupam Rama61% | $53 → $57 | Maintains | Overweight | Get Alert |
| 03/07/2023 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | -26.98% | Anupam Rama61% | $18 → $23 | Maintains | Overweight | Get Alert |
| 03/03/2023 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 181.73% | Anupam Rama61% | $153 → $206 | Maintains | Overweight | Get Alert |
| 01/30/2023 | GTHX | Buy Now | G1 Therapeutics | — | — | Anupam Rama61% | $7 → $10 | Upgrade | Underweight → Neutral | Get Alert |
| 01/20/2023 | CYT | Buy Now | Cyteir Therapeutics | — | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 01/03/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $12.62 | 224.88% | Anupam Rama61% | → $41 | Initiates | → Overweight | Get Alert |
| 12/09/2022 | RLYB | Buy Now | Rallybio | $0.74 | 2736.69% | Anupam Rama61% | → $21 | Initiates | → Overweight | Get Alert |
| 12/06/2022 | SAGE | Buy Now | Sage Therapeutics | $7.84 | 665.31% | Anupam Rama61% | $92 → $60 | Maintains | Overweight | Get Alert |
| 11/18/2022 | ZLAB | Buy Now | Zai Lab | $37.92 | 108.33% | Anupam Rama61% | $96 → $79 | Maintains | Overweight | Get Alert |
| 11/18/2022 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | -39.68% | Anupam Rama61% | $20 → $19 | Maintains | Overweight | Get Alert |
| 11/18/2022 | VERA | Buy Now | Vera Therapeutics | $27.41 | 38.64% | Anupam Rama61% | $35 → $38 | Maintains | Overweight | Get Alert |
| 11/18/2022 | ANAB | Buy Now | AnaptysBio | $16.14 | 98.27% | Anupam Rama61% | $24 → $32 | Maintains | Underweight | Get Alert |
| 11/15/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 223.64% | Anupam Rama61% | $81 → $79 | Maintains | Overweight | Get Alert |
| 11/10/2022 | ELEV | Buy Now | Elevation Oncology | $0.48 | — | Anupam Rama61% | — | Downgrade | Neutral → Underweight | Get Alert |
| 11/10/2022 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | — | Anupam Rama61% | — | Downgrade | Overweight → Underweight | Get Alert |
| 11/03/2022 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | 30.36% | Anupam Rama61% | $138 → $143 | Maintains | Overweight | Get Alert |
| 09/30/2022 | SLDB | Buy Now | Solid Biosciences | $5.01 | — | Anupam Rama61% | — | Upgrade | Underweight → Neutral | Get Alert |
| 09/26/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | Anupam Rama61% | $109 → $94 | Maintains | Overweight | Get Alert |
| 08/08/2022 | ELEV | Buy Now | Elevation Oncology | $0.48 | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/13/2022 | ATRA | Buy Now | Atara Biotherapeutics | $7.20 | 38.89% | Anupam Rama61% | → $250 | Downgrade | Overweight → Neutral | Get Alert |
| 07/12/2022 | VERA | Buy Now | Vera Therapeutics | $27.41 | 27.69% | Anupam Rama61% | → $35 | Initiates | → Overweight | Get Alert |
| 04/04/2022 | ZLAB | Buy Now | Zai Lab | $37.92 | 195.36% | Anupam Rama61% | $136 → $112 | Maintains | Overweight | Get Alert |
| 04/04/2022 | REPL | Buy Now | Replimune Group | $11.43 | 241.21% | Anupam Rama61% | $47 → $39 | Maintains | Overweight | Get Alert |
| 04/04/2022 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | 14.86% | Anupam Rama61% | $125 → $126 | Maintains | Overweight | Get Alert |
| 04/04/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 182.67% | Anupam Rama61% | $66 → $69 | Maintains | Overweight | Get Alert |
| 03/28/2022 | ATRA | Buy Now | Atara Biotherapeutics | $7.20 | 205.56% | Anupam Rama61% | $675 → $550 | Maintains | Overweight | Get Alert |
| 03/11/2022 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | -42.86% | Anupam Rama61% | $21 → $18 | Maintains | Overweight | Get Alert |
| 03/08/2022 | PASG | Buy Now | Passage Bio | $0.47 | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 02/24/2022 | KOD | Buy Now | Kodiak Sciences | $3.24 | 548.15% | Anupam Rama61% | $90 → $21 | Downgrade | Overweight → Neutral | Get Alert |
| 02/02/2022 | KOD | Buy Now | Kodiak Sciences | $3.24 | 2677.78% | Anupam Rama61% | → $90 | Upgrade | Neutral → Overweight | Get Alert |
| 01/03/2022 | ATRA | Buy Now | Atara Biotherapeutics | $7.20 | 275% | Anupam Rama61% | $650 → $675 | Maintains | Overweight | Get Alert |
| 12/15/2021 | ZLAB | Buy Now | Zai Lab | $37.92 | 258.65% | Anupam Rama61% | $189 → $136 | Maintains | Overweight | Get Alert |
| 12/10/2021 | CYTK | Buy Now | Cytokinetics | $43.48 | 33.39% | Anupam Rama61% | → $58 | Initiates | → Overweight | Get Alert |
| 12/09/2021 | RAPT | Buy Now | RAPT Therapeutics | $1.10 | 5445.45% | Anupam Rama61% | → $61 | Initiates | → Overweight | Get Alert |
| 11/17/2021 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | 13.04% | Anupam Rama61% | → $124 | Upgrade | Neutral → Overweight | Get Alert |
| 11/16/2021 | ORTX | Buy Now | Orchard Therapeutics | — | — | Anupam Rama61% | — | Downgrade | Neutral → Underweight | Get Alert |
| 11/09/2021 | OYST | Buy Now | Oyster Point Pharma | — | — | Anupam Rama61% | $30 → $23 | Downgrade | Overweight → Neutral | Get Alert |
| 11/05/2021 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 77.79% | Anupam Rama61% | $88 → $130 | Upgrade | Neutral → Overweight | Get Alert |
| 11/05/2021 | TBPH | Buy Now | Theravance Biopharma | $9.21 | 30.29% | Anupam Rama61% | $7 → $12 | Upgrade | Underweight → Neutral | Get Alert |
| 11/04/2021 | GTHX | Buy Now | G1 Therapeutics | — | — | Anupam Rama61% | $20 → $19 | Downgrade | Neutral → Underweight | Get Alert |
| 10/25/2021 | VIR | Buy Now | Vir Biotechnology | $6.93 | 433.91% | Anupam Rama61% | $29 → $37 | Upgrade | Underweight → Neutral | Get Alert |
| 10/12/2021 | PTGX | Buy Now | Protagonist Therapeutics | $54.25 | 1.38% | Anupam Rama61% | → $55 | Upgrade | Neutral → Overweight | Get Alert |
| 10/11/2021 | CCXI | Buy Now | ChemoCentryx | — | — | Anupam Rama61% | $14 → $38 | Upgrade | Underweight → Neutral | Get Alert |
| 09/30/2021 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 77.99% | Anupam Rama61% | → $16 | Upgrade | Neutral → Overweight | Get Alert |
| 09/30/2021 | GTHX | Buy Now | G1 Therapeutics | — | — | Anupam Rama61% | $24 → $20 | Downgrade | Overweight → Neutral | Get Alert |
| 09/20/2021 | PTGX | Buy Now | Protagonist Therapeutics | $54.25 | -9.68% | Anupam Rama61% | → $49 | Downgrade | Overweight → Neutral | Get Alert |
| 09/08/2021 | SWTX | Buy Now | SpringWorks Therapeutics | $49.65 | 111.48% | Anupam Rama61% | $97 → $105 | Maintains | Overweight | Get Alert |
| 08/23/2021 | NUVL | Buy Now | Nuvalent | $76.66 | -55.65% | Anupam Rama61% | → $34 | Initiates | → Overweight | Get Alert |
| 08/18/2021 | ORTX | Buy Now | Orchard Therapeutics | — | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/10/2021 | ERAS | Buy Now | Erasca | $1.40 | 1900% | Anupam Rama61% | → $28 | Initiates | → Overweight | Get Alert |
| 08/05/2021 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 18.98% | Anupam Rama61% | $92 → $87 | Upgrade | Underweight → Neutral | Get Alert |
| 08/02/2021 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Anupam Rama61% | → $6 | Upgrade | Neutral → Overweight | Get Alert |
| 07/13/2021 | CYT | Buy Now | Cyteir Therapeutics | — | — | Anupam Rama61% | → $30 | Initiates | → Overweight | Get Alert |
| 07/02/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 313.76% | Anupam Rama61% | $91 → $101 | Maintains | Overweight | Get Alert |
| 06/21/2021 | DAWN | Buy Now | Day One Biopharmaceutical | $8.16 | 365.69% | Anupam Rama61% | → $38 | Initiates | → Overweight | Get Alert |
| 05/13/2021 | ATRA | Buy Now | Atara Biotherapeutics | $7.20 | 302.78% | Anupam Rama61% | $575 → $725 | Upgrade | Neutral → Overweight | Get Alert |
| 05/07/2021 | CCXI | Buy Now | ChemoCentryx | — | — | Anupam Rama61% | $57 → $17 | Downgrade | Neutral → Underweight | Get Alert |
| 03/29/2021 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 2233.33% | Anupam Rama61% | → $14 | Initiates | → Overweight | Get Alert |
| 03/01/2021 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 73.08% | Anupam Rama61% | → $54 | Downgrade | Overweight → Neutral | Get Alert |
| 02/12/2021 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 111.36% | Anupam Rama61% | → $19 | Downgrade | Overweight → Neutral | Get Alert |
| 02/11/2021 | ANAB | Buy Now | AnaptysBio | $16.14 | 147.83% | Anupam Rama61% | $19 → $40 | Upgrade | Underweight → Overweight | Get Alert |
| 02/05/2021 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Anupam Rama61% | — | Upgrade | Underweight → Neutral | Get Alert |
| 01/27/2021 | VIR | Buy Now | Vir Biotechnology | $6.93 | 332.9% | Anupam Rama61% | → $30 | Downgrade | Neutral → Underweight | Get Alert |
| 01/27/2021 | FREQ | Buy Now | Frequency Therapeutics | — | — | Anupam Rama61% | → $2800 | Upgrade | Neutral → Overweight | Get Alert |
| 01/11/2021 | BCAB | Buy Now | BioAtla | $0.33 | 13495.17% | Anupam Rama61% | → $45 | Initiates | → Overweight | Get Alert |
| 01/08/2021 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 31.29% | Anupam Rama61% | → $96 | Downgrade | Overweight → Underweight | Get Alert |
| 01/06/2021 | PTGX | Buy Now | Protagonist Therapeutics | $54.25 | -35.48% | Anupam Rama61% | → $35 | Initiates | → Overweight | Get Alert |
| 01/04/2021 | PASG | Buy Now | Passage Bio | $0.47 | 7354.74% | Anupam Rama61% | $25 → $35 | Upgrade | Neutral → Overweight | Get Alert |
| 11/30/2020 | KOD | Buy Now | Kodiak Sciences | $3.24 | 3758.02% | Anupam Rama61% | → $125 | Downgrade | Overweight → Neutral | Get Alert |
| 10/29/2020 | CCXI | Buy Now | ChemoCentryx | — | — | Anupam Rama61% | $63 → $60 | Downgrade | Overweight → Neutral | Get Alert |
| 10/12/2020 | DYN | Buy Now | Dyne Therapeutics | $12.58 | 114.63% | Anupam Rama61% | → $27 | Initiates | → Overweight | Get Alert |
| 09/11/2020 | VIR | Buy Now | Vir Biotechnology | $6.93 | 318.47% | Anupam Rama61% | $30 → $29 | Upgrade | Underweight → Neutral | Get Alert |
| 08/24/2020 | ALVR | Buy Now | AlloVir | $9.67 | 417.06% | Anupam Rama61% | → $1150 | Initiates | → Overweight | Get Alert |
| 08/18/2020 | ITOS | Buy Now | ITeos Therapeutics | $7.09 | 464.17% | Anupam Rama61% | → $40 | Initiates | → Overweight | Get Alert |
| 08/14/2020 | PASG | Buy Now | Passage Bio | $0.47 | 5224.81% | Anupam Rama61% | → $25 | Downgrade | Overweight → Neutral | Get Alert |
| 08/04/2020 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | 23.97% | Anupam Rama61% | → $136 | Downgrade | Overweight → Neutral | Get Alert |
| 07/29/2020 | CCXI | Buy Now | ChemoCentryx | — | — | Anupam Rama61% | $64 → $61 | Maintains | Overweight | Get Alert |
| 07/13/2020 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 51.6% | Anupam Rama61% | → $28 | Upgrade | Neutral → Overweight | Get Alert |
| 07/07/2020 | GBIO | Buy Now | Generation Bio | $0.57 | 4812.28% | Anupam Rama61% | → $28 | Initiates | → Overweight | Get Alert |
| 07/07/2020 | TBPH | Buy Now | Theravance Biopharma | $9.21 | 214.88% | Anupam Rama61% | → $29 | Initiates | → Overweight | Get Alert |
| 06/18/2020 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | 22.15% | Anupam Rama61% | $122 → $134 | Maintains | Overweight | Get Alert |
| 06/08/2020 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 129.41% | Anupam Rama61% | $54 → $56 | Maintains | Overweight | Get Alert |
| 05/18/2020 | FREQ | Buy Now | Frequency Therapeutics | — | — | Anupam Rama61% | → $1350 | Downgrade | Overweight → Neutral | Get Alert |
| 05/14/2020 | CCXI | Buy Now | ChemoCentryx | — | — | Anupam Rama61% | $61 → $64 | Maintains | Overweight | Get Alert |
| 05/14/2020 | EIDX | Buy Now | Eidos Therapeutics | — | — | Anupam Rama61% | $58 → $50 | Downgrade | Overweight → Neutral | Get Alert |
| 05/12/2020 | GTHX | Buy Now | G1 Therapeutics | — | — | Anupam Rama61% | $33 → $23 | Maintains | Overweight | Get Alert |
| 05/12/2020 | ATRA | Buy Now | Atara Biotherapeutics | $7.20 | 219.44% | Anupam Rama61% | $550 → $575 | Maintains | Neutral | Get Alert |
| 05/07/2020 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -43.92% | Anupam Rama61% | $133 → $137 | Downgrade | Overweight → Neutral | Get Alert |
| 05/04/2020 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 162.82% | Anupam Rama61% | $72 → $82 | Maintains | Overweight | Get Alert |
| 05/01/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | Anupam Rama61% | — | Upgrade | Neutral → Overweight | Get Alert |
| 03/27/2020 | FREQ | Buy Now | Frequency Therapeutics | — | — | Anupam Rama61% | $1300 → $1400 | Maintains | Overweight | Get Alert |
| 03/19/2020 | VIR | Buy Now | Vir Biotechnology | $6.93 | 275.18% | Anupam Rama61% | → $26 | Downgrade | Neutral → Underweight | Get Alert |
| 03/12/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | Anupam Rama61% | → $88 | Upgrade | Underweight → Neutral | Get Alert |
| 03/11/2020 | CCXI | Buy Now | ChemoCentryx | — | — | Anupam Rama61% | $60 → $61 | Maintains | Overweight | Get Alert |
| 03/03/2020 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 36.51% | Anupam Rama61% | $38 → $43 | Maintains | Overweight | Get Alert |
| 02/28/2020 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 118.82% | Anupam Rama61% | $172 → $160 | Maintains | Overweight | Get Alert |
| 02/18/2020 | CCXI | Buy Now | ChemoCentryx | — | — | Anupam Rama61% | $28 → $60 | Maintains | Overweight | Get Alert |
| 02/04/2020 | VIR | Buy Now | Vir Biotechnology | $6.93 | 275.18% | Anupam Rama61% | $25 → $26 | Downgrade | Overweight → Neutral | Get Alert |
| 12/24/2019 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.54 | 759.03% | Anupam Rama61% | → $39 | Initiates | → Overweight | Get Alert |
| 12/24/2019 | KOD | Buy Now | Kodiak Sciences | $3.24 | 2430.86% | Anupam Rama61% | → $82 | Initiates | → Overweight | Get Alert |
| 12/04/2019 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 117.95% | Anupam Rama61% | $80 → $68 | Maintains | Overweight | Get Alert |
| 11/25/2019 | OYST | Buy Now | Oyster Point Pharma | — | — | Anupam Rama61% | → $26 | Initiates | → Overweight | Get Alert |
| 11/08/2019 | ATRA | Buy Now | Atara Biotherapeutics | $7.20 | 205.56% | Anupam Rama61% | $1075 → $550 | Downgrade | Overweight → Neutral | Get Alert |
| 11/05/2019 | VIR | Buy Now | Vir Biotechnology | $6.93 | 260.75% | Anupam Rama61% | → $25 | Initiates | → Overweight | Get Alert |
| 10/28/2019 | FREQ | Buy Now | Frequency Therapeutics | — | — | Anupam Rama61% | → $1250 | Initiates | → Overweight | Get Alert |
| 10/08/2019 | SWTX | Buy Now | SpringWorks Therapeutics | $49.65 | -35.55% | Anupam Rama61% | → $32 | Initiates | → Overweight | Get Alert |
| 10/03/2019 | DOVA | Buy Now | Dova Pharmaceuticals | — | — | Anupam Rama61% | $16 → $28 | Upgrade | Underweight → Neutral | Get Alert |
| 09/12/2019 | CCXI | Buy Now | ChemoCentryx | — | — | Anupam Rama61% | $16 → $14 | Upgrade | Neutral → Overweight | Get Alert |
| 08/08/2019 | GTHX | Buy Now | G1 Therapeutics | — | — | Anupam Rama61% | $38 → $45 | Upgrade | Neutral → Overweight | Get Alert |
| 08/02/2019 | MRTX | Buy Now | Mirati Therapeutics | — | — | Anupam Rama61% | — | Downgrade | Neutral → Underweight | Get Alert |
| 07/22/2019 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 20.63% | Anupam Rama61% | → $38 | Initiates | → Overweight | Get Alert |
| 07/12/2019 | MRTX | Buy Now | Mirati Therapeutics | — | — | Anupam Rama61% | $70 → $101 | Maintains | Neutral | Get Alert |
| 07/12/2019 | DOVA | Buy Now | Dova Pharmaceuticals | — | — | Anupam Rama61% | $13 → $15 | Maintains | Underweight | Get Alert |
| 07/12/2019 | ARRY | Buy Now | Array Technologies | $6.25 | 668% | Anupam Rama61% | $29 → $48 | Downgrade | Overweight → Neutral | Get Alert |
| 07/12/2019 | REPL | Buy Now | Replimune Group | $11.43 | 127.47% | Anupam Rama61% | $27 → $26 | Upgrade | Neutral → Overweight | Get Alert |
| 07/12/2019 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 100.74% | Anupam Rama61% | $35 → $49 | Upgrade | Neutral → Overweight | Get Alert |
| 06/17/2019 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | -18.79% | Anupam Rama61% | → $15 | Initiates | → Neutral | Get Alert |
| 04/22/2019 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | -3.37% | Anupam Rama61% | $100 → $106 | Upgrade | Neutral → Overweight | Get Alert |
| 04/17/2019 | MRTX | Buy Now | Mirati Therapeutics | — | — | Anupam Rama61% | — | Initiates | → Neutral | Get Alert |
| 01/23/2019 | REPL | Buy Now | Replimune Group | $11.43 | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 01/23/2019 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | -8.84% | Anupam Rama61% | $97 → $100 | Downgrade | Overweight → Neutral | Get Alert |
| 01/23/2019 | GTHX | Buy Now | G1 Therapeutics | — | — | Anupam Rama61% | $59 → $41 | Downgrade | Overweight → Neutral | Get Alert |
| 01/23/2019 | EIDX | Buy Now | Eidos Therapeutics | — | — | Anupam Rama61% | → $29 | Downgrade | Overweight → Neutral | Get Alert |
| 01/23/2019 | DOVA | Buy Now | Dova Pharmaceuticals | — | — | Anupam Rama61% | → $20 | Downgrade | Overweight → Underweight | Get Alert |
| 01/23/2019 | LJPC | Buy Now | La Jolla Pharmaceutical | — | — | Anupam Rama61% | $18 → $9 | Upgrade | Underweight → Neutral | Get Alert |
| 01/23/2019 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 39.29% | Anupam Rama61% | → $34 | Downgrade | Overweight → Neutral | Get Alert |
| 11/21/2018 | ANAB | Buy Now | AnaptysBio | $16.14 | 612.52% | Anupam Rama61% | → $115 | Initiates | → Overweight | Get Alert |
| 11/14/2018 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 39.29% | Anupam Rama61% | $38 → $34 | Maintains | Overweight | Get Alert |
| 11/12/2018 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Anupam Rama61% | — | Downgrade | Neutral → Underweight | Get Alert |
| 08/14/2018 | CCXI | Buy Now | ChemoCentryx | — | — | Anupam Rama61% | $14 → $15 | Downgrade | Overweight → Neutral | Get Alert |
| 08/14/2018 | REPL | Buy Now | Replimune Group | $11.43 | 127.47% | Anupam Rama61% | → $26 | Initiates | → Overweight | Get Alert |
| 08/10/2018 | LJPC | Buy Now | La Jolla Pharmaceutical | — | — | Anupam Rama61% | $24 → $21 | Maintains | Underweight | Get Alert |
| 08/10/2018 | MYOK | Buy Now | MyoKardia | — | — | Anupam Rama61% | $80 → $81 | Maintains | Overweight | Get Alert |
| 08/10/2018 | GTHX | Buy Now | G1 Therapeutics | — | — | Anupam Rama61% | $58 → $63 | Maintains | Overweight | Get Alert |
| 07/27/2018 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Anupam Rama61% | $184 → $188 | Maintains | Overweight | Get Alert |
| 07/16/2018 | EIDX | Buy Now | Eidos Therapeutics | — | — | Anupam Rama61% | → $36 | Initiates | → Overweight | Get Alert |
| 05/10/2018 | DVAX | Buy Now | Dynavax Technologies | $13.90 | — | Anupam Rama61% | — | Upgrade | Neutral → Overweight | Get Alert |
| 05/01/2018 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | -6.11% | Anupam Rama61% | $100 → $103 | Maintains | Overweight | Get Alert |
| 04/10/2018 | ATRA | Buy Now | Atara Biotherapeutics | $7.20 | 677.78% | Anupam Rama61% | → $1400 | Initiates | → Overweight | Get Alert |
| 03/23/2018 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 43.38% | Anupam Rama61% | $31 → $35 | Maintains | Overweight | Get Alert |
| 03/19/2018 | OPHT | Buy Now | Ophthotech | — | — | Anupam Rama61% | — | Downgrade | Neutral → Underweight | Get Alert |
| 03/19/2018 | OTIC | Buy Now | Otonomy | — | — | Anupam Rama61% | — | Downgrade | Neutral → Underweight | Get Alert |
| 03/15/2018 | SLDB | Buy Now | Solid Biosciences | $5.01 | — | Anupam Rama61% | — | Downgrade | Neutral → Underweight | Get Alert |
| 03/14/2018 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 29.92% | Anupam Rama61% | $75 → $95 | Maintains | Overweight | Get Alert |
| 03/13/2018 | CCXI | Buy Now | ChemoCentryx | — | — | Anupam Rama61% | $13 → $16 | Maintains | Overweight | Get Alert |
| 03/06/2018 | GTHX | Buy Now | G1 Therapeutics | — | — | Anupam Rama61% | $33 → $39 | Maintains | Overweight | Get Alert |
| 03/06/2018 | CLSD | Buy Now | Clearside Biomedical | $0.95 | 1793.94% | Anupam Rama61% | $15 → $18 | Maintains | Overweight | Get Alert |
| 02/21/2018 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | 2.57% | Anupam Rama61% | $63 → $75 | Maintains | Overweight | Get Alert |
| 02/20/2018 | SLDB | Buy Now | Solid Biosciences | $5.01 | 458.88% | Anupam Rama61% | → $420 | Initiates | → Neutral | Get Alert |
| 02/15/2018 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 172.44% | Anupam Rama61% | $76 → $85 | Maintains | Overweight | Get Alert |
| 02/14/2018 | DVAX | Buy Now | Dynavax Technologies | $13.90 | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 02/14/2018 | ZLAB | Buy Now | Zai Lab | $37.92 | -7.7% | Anupam Rama61% | $32 → $35 | Maintains | Overweight | Get Alert |
| 02/14/2018 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | -8.84% | Anupam Rama61% | $79 → $100 | Maintains | Overweight | Get Alert |
| 02/14/2018 | ZLAB | Buy Now | Zai Lab | $37.92 | — | Anupam Rama61% | — | Upgrade | Neutral → Overweight | Get Alert |
| 12/12/2017 | MYOK | Buy Now | MyoKardia | — | — | Anupam Rama61% | → $54 | Initiates | → Overweight | Get Alert |
| 12/08/2017 | LJPC | Buy Now | La Jolla Pharmaceutical | — | — | Anupam Rama61% | — | Downgrade | Overweight → Underweight | Get Alert |
| 12/04/2017 | IFRX | Buy Now | InflaRx | $1.24 | 2319.75% | Anupam Rama61% | → $30 | Initiates | → Overweight | Get Alert |
| 12/04/2017 | APLS | Buy Now | Apellis Pharmaceuticals | $24.41 | 27% | Anupam Rama61% | → $31 | Initiates | → Overweight | Get Alert |
| 11/16/2017 | PTCT | Buy Now | PTC Therapeutics | $56.00 | — | Anupam Rama61% | — | Upgrade | Underweight → Neutral | Get Alert |
| 11/09/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | — | Anupam Rama61% | — | Upgrade | Neutral → Overweight | Get Alert |
| 10/16/2017 | ZLAB | Buy Now | Zai Lab | $37.92 | -15.61% | Anupam Rama61% | → $32 | Initiates | → Neutral | Get Alert |
| 10/12/2017 | RXDX | Buy Now | Prometheus Biosciences | — | — | Anupam Rama61% | $18 → $20 | Maintains | Overweight | Get Alert |
| 10/09/2017 | PTCT | Buy Now | PTC Therapeutics | $56.00 | — | Anupam Rama61% | — | Downgrade | Neutral → Underweight | Get Alert |
| 09/05/2017 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Anupam Rama61% | — | Upgrade | Neutral → Overweight | Get Alert |
| 08/30/2017 | OTIC | Buy Now | Otonomy | — | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/30/2017 | LJPC | Buy Now | La Jolla Pharmaceutical | — | — | Anupam Rama61% | → $36 | Initiates | → Overweight | Get Alert |
| 08/15/2017 | OTIC | Buy Now | Otonomy | — | — | Anupam Rama61% | — | Upgrade | Neutral → Overweight | Get Alert |
| 07/24/2017 | DOVA | Buy Now | Dova Pharmaceuticals | — | — | Anupam Rama61% | → $35 | Initiates | → Overweight | Get Alert |
| 07/21/2017 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 06/12/2017 | GTHX | Buy Now | G1 Therapeutics | — | — | Anupam Rama61% | → $23 | Initiates | → Overweight | Get Alert |
| 05/03/2017 | ARRY | Buy Now | Array Technologies | $6.25 | — | Anupam Rama61% | — | Upgrade | Neutral → Overweight | Get Alert |
| 02/24/2017 | CLSD | Buy Now | Clearside Biomedical | $0.95 | 1899.16% | Anupam Rama61% | → $19 | Initiates | → Overweight | Get Alert |
| 02/03/2017 | ARRY | Buy Now | Array Technologies | $6.25 | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 12/22/2016 | SRPT | Buy Now | Sarepta Therapeutics | $73.12 | -45.3% | Anupam Rama61% | → $40 | Initiates | → Overweight | Get Alert |
| 12/12/2016 | OPHT | Buy Now | Ophthotech | — | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 09/08/2016 | OPHT | Buy Now | Ophthotech | — | — | Anupam Rama61% | $81 → $95 | Maintains | Overweight | Get Alert |
| 08/05/2016 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 966.67% | Anupam Rama61% | $15 → $16 | Maintains | Overweight | Get Alert |
| 08/05/2016 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -66.03% | Anupam Rama61% | $80 → $83 | Maintains | Overweight | Get Alert |
| 06/23/2016 | RXDX | Buy Now | Prometheus Biosciences | — | — | Anupam Rama61% | → $15 | Initiates | → Overweight | Get Alert |
| 06/13/2016 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 98.72% | Anupam Rama61% | $50 → $62 | Upgrade | Neutral → Overweight | Get Alert |
| 06/02/2016 | OPHT | Buy Now | Ophthotech | — | — | Anupam Rama61% | $60 → $84 | Upgrade | Neutral → Overweight | Get Alert |
| 03/11/2016 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -66.84% | Anupam Rama61% | $111 → $81 | Upgrade | Neutral → Overweight | Get Alert |
| 02/24/2016 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Anupam Rama61% | $15 → $13 | Maintains | Overweight | Get Alert |
| 02/23/2016 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 66.87% | Anupam Rama61% | $18 → $15 | Maintains | Overweight | Get Alert |
| 02/09/2016 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | -42.57% | Anupam Rama61% | $70 → $63 | Maintains | Overweight | Get Alert |
| 09/08/2015 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 211.48% | Anupam Rama61% | $22 → $28 | Maintains | Overweight | Get Alert |
| 08/07/2015 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -52.93% | Anupam Rama61% | $125 → $115 | Maintains | Neutral | Get Alert |
| 08/07/2015 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -52.93% | Anupam Rama61% | $125 → $115 | Downgrade | Overweight → Neutral | Get Alert |
| 05/22/2015 | OTIC | Buy Now | Otonomy | — | — | Anupam Rama61% | $42 → $30 | Downgrade | Overweight → Neutral | Get Alert |
| 05/18/2015 | CCXI | Buy Now | ChemoCentryx | — | — | Anupam Rama61% | $7 → $14 | Upgrade | Neutral → Overweight | Get Alert |
| 03/19/2015 | OTIC | Buy Now | Otonomy | — | — | Anupam Rama61% | $32 → $42 | Maintains | Overweight | Get Alert |
| 03/19/2015 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | -50.77% | Anupam Rama61% | → $54 | Initiates | → Overweight | Get Alert |
| 01/26/2015 | ARRY | Buy Now | Array Technologies | $6.25 | 44% | Anupam Rama61% | $8 → $9 | Maintains | Overweight | Get Alert |
| 12/24/2014 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -56.61% | Anupam Rama61% | $90 → $106 | Maintains | Overweight | Get Alert |
| 12/16/2014 | OPHT | Buy Now | Ophthotech Corp. | — | — | Anupam Rama61% | $51 → $60 | Maintains | Overweight | Get Alert |
| 12/02/2014 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 188.46% | Anupam Rama61% | $60 → $90 | Downgrade | Overweight → Neutral | Get Alert |
| 11/17/2014 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | 0.12% | Anupam Rama61% | $8 → $9 | Maintains | Overweight | Get Alert |
| 06/30/2014 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | — | Anupam Rama61% | — | Upgrade | → Overweight | Get Alert |
| 06/16/2014 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 92.31% | Anupam Rama61% | $55 → $60 | Maintains | Overweight | Get Alert |
| 05/20/2014 | OPHT | Buy Now | Ophthotech Corp. | — | — | Anupam Rama61% | $40 → $51 | Maintains | Overweight | Get Alert |
| 05/07/2014 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Anupam Rama61% | $24 → $20 | Maintains | Overweight | Get Alert |
| 04/07/2014 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 76.28% | Anupam Rama61% | $40 → $55 | Upgrade | Neutral → Overweight | Get Alert |
| 03/28/2014 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 28.21% | Anupam Rama61% | $35 → $40 | Maintains | Neutral | Get Alert |
| 11/21/2013 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 10/21/2013 | OPHT | Buy Now | Ophthotech Corp. | — | — | Anupam Rama61% | → $40 | Initiates | → Overweight | Get Alert |
| 09/10/2013 | CCXI | Buy Now | ChemoCentryx | — | — | Anupam Rama61% | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/19/2013 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 12.18% | Anupam Rama61% | → $35 | Initiates | → Neutral | Get Alert |
| 07/12/2013 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -77.49% | Anupam Rama61% | $28 → $55 | Maintains | Overweight | Get Alert |
| 05/07/2013 | ARRY | Buy Now | Array Technologies | $6.25 | 12% | Anupam Rama61% | $6 → $7 | Maintains | Overweight | Get Alert |
| 03/06/2013 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Anupam Rama61% | $42 → $53 | Maintains | Overweight | Get Alert |
| 01/31/2013 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Anupam Rama61% | → $42 | Initiates | → Overweight | Get Alert |
| 12/20/2012 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | -44.38% | Anupam Rama61% | $9 → $5 | Maintains | Overweight | Get Alert |
| 05/08/2012 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -93.86% | Anupam Rama61% | → $15 | Initiates | → Overweight | Get Alert |
| 05/08/2012 | FOLD | Buy Now | Amicus Therapeutics | $8.99 | -11.01% | Anupam Rama61% | → $8 | Upgrade | Neutral → Buy | Get Alert |
| 03/19/2012 | CCXI | Buy Now | Chemocentryx | — | — | Anupam Rama61% | → $16 | Initiates | → Overweight | Get Alert |
